Date de publication
Géographie
Langue de la ressource
Texte disponible en version intégrale
Open Access / OK to Reproduce
Évalué par des pairs
L’objectif
Despite its proven efficacy, accessing methadone in the United States remains challenging due to regulatory barriers. This article examines the complex landscape of methadone regulation in the USA across federal, state, and local levels, highlighting disparities and opportunities for reform.
Constatations/points à retenir
Regulatory flexibility during COVID-19 improved methadone treatment experiences and retention, highlighting the potential benefits of permanent regulatory reforms. The Association for Multidisciplinary Education, Research, Substance Use, and Addiction (AMERSA) advocates for expanded methadone treatment, including into primary care and community pharmacies, emphasizing the need for coordinated efforts to enhance accessibility and combat the overdose crisis.
